[HTML][HTML] Stable gastric pentadecapeptide BPC 157 may recover brain–gut axis and gut–brain axis function
P Sikiric, S Gojkovic, I Krezic, IM Smoday, L Kalogjera… - Pharmaceuticals, 2023 - mdpi.com
Conceptually, a wide beneficial effect, both peripherally and centrally, might have been
essential for the harmony of brain–gut and gut–brain axes' function. Seen from the original …
essential for the harmony of brain–gut and gut–brain axes' function. Seen from the original …
[HTML][HTML] Stable gastric pentadecapeptide BPC 157 as useful cytoprotective peptide therapy in the heart disturbances, myocardial infarction, heart failure, pulmonary …
P Sikiric, M Udovicic, I Barisic, D Balenovic… - Biomedicines, 2022 - mdpi.com
In heart disturbances, stable gastric pentadecapeptide BPC 157 especial therapy effects
combine the therapy of myocardial infarction, heart failure, pulmonary hypertension …
combine the therapy of myocardial infarction, heart failure, pulmonary hypertension …
[HTML][HTML] Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
L Kalogjera, I Krezic, IM Smoday, H Vranes… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Using rat stomach perforation as a prototypic direct lesion applied in
cytoprotection research, we focused on the first demonstration of the severe …
cytoprotection research, we focused on the first demonstration of the severe …
Stable gastric pentadecapeptide BPC 157: Prompt particular activation of collateral pathways
P Sikiric, S Gojkovic, M Knezevic… - Current medicinal …, 2023 - ingentaconnect.com
[3-17]. Progressive venous and arterial thrombosis, both peripherally and centrally (in the
Virchow causeconsequence triad, evidencing counteracted stasis and recovered …
Virchow causeconsequence triad, evidencing counteracted stasis and recovered …
[HTML][HTML] Therapy effect of the stable gastric pentadecapeptide BPC 157 on acute pancreatitis as vascular failure-induced severe peripheral and central syndrome in …
IM Smoday, I Petrovic, L Kalogjera, H Vranes, H Zizek… - Biomedicines, 2022 - mdpi.com
We revealed the therapy effect of the stable gastric pentadecapeptide BPC 157 (10 μg/kg,
10 ng/kg ig or po) with specific activation of the collateral rescuing pathways, the azygos …
10 ng/kg ig or po) with specific activation of the collateral rescuing pathways, the azygos …
[HTML][HTML] Stable gastric pentadecapeptide BPC 157 may counteract myocardial infarction induced by isoprenaline in rats
I Barisic, D Balenovic, M Udovicic, D Bardak, D Strinic… - Biomedicines, 2022 - mdpi.com
We revealed that the stable gastric pentadecapeptide BPC 157, a useful peptide therapy
against isoprenaline myocardial infarction, as well as against isoprenaline myocardial …
against isoprenaline myocardial infarction, as well as against isoprenaline myocardial …
[HTML][HTML] Antiarrhythmic sotalol, occlusion/occlusion-like syndrome in rats, and stable gastric pentadecapeptide BPC 157 therapy
I Premuzic Mestrovic, IM Smoday, L Kalogjera, I Krezic… - Pharmaceuticals, 2023 - mdpi.com
We focused on the first demonstration that antiarrhythmics, particularly class II and class III
antiarrhythmic and beta-blocker sotalol can induce severe occlusion/occlusion-like …
antiarrhythmic and beta-blocker sotalol can induce severe occlusion/occlusion-like …
[HTML][HTML] Over-dose lithium toxicity as an occlusive-like syndrome in rats and gastric pentadecapeptide BPC 157
S Strbe, S Gojkovic, I Krezic, H Zizek, H Vranes… - Biomedicines, 2021 - mdpi.com
Due to endothelial impairment, high-dose lithium may produce an occlusive-like syndrome,
comparable to permanent occlusion of major vessel-induced syndromes in rats; intracranial …
comparable to permanent occlusion of major vessel-induced syndromes in rats; intracranial …
[HTML][HTML] Stable gastric pentadecapeptide BPC 157 and striated, smooth, and heart muscle
First, we review the definitively severed myotendinous junction and recovery by the
cytoprotective stable gastric pentadecapeptide BPC 157 therapy, its healing that might …
cytoprotective stable gastric pentadecapeptide BPC 157 therapy, its healing that might …
[HTML][HTML] Pentadecapeptide BPC 157 as therapy for inferior caval vein embolization: Recovery of sodium laurate-post-embolization syndrome in rats
IM Smoday, I Krezic, L Kalogjera, V Vukovic, H Zizek… - Pharmaceuticals, 2023 - mdpi.com
After inferior caval vein embolization therapy, post-embolization syndrome (sodium laurate
10 mg/kg, 0.1 mL into rat inferior caval vein, assessment at 15, 30, 60 min, prime lung …
10 mg/kg, 0.1 mL into rat inferior caval vein, assessment at 15, 30, 60 min, prime lung …